During ECCO 2024, held from February 21st to 24th, international IBD specialists came to Stockholm to present the latest news in IBD care. In this setting, our colleagues Oliver Dähn and Christian Reinhard had the privilege of presenting the following two posters: Poster 1: P437 - Feasibility study of a Point-of-Care assay for rapid
Read more
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
Interview with the Dr. Risch AIOS-Team about the successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay
Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.
Interview with Christophe Zehnder about the successful introduction of the fully automated Seegene STARlet-AIOS system with the AllplexTM STI Essential Assay and the AllplexTM GI-EB Screening Assay
Social Links